CPT Pharmacometrics Syst Pharmacol May 2023 PMID 36597353

Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report.

Abdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, Partha Roy, Neil John Parrott, Lanyan Fang, Nilufer Tampal, Yuching Yang, Rebeka Jereb, Liang Zhao, Fang Wu

Full text PDF Download social card

Mentions

Peak: 4 in Jun 2023

across 3 sources since Jun 2023

Extended reach

3,228

potential audience

Total likes

Video views

Mentions per month

Jun 2023 – Sep 2023

Where it's discussed

X / Twitter4 posts
Facebook2 posts
YouTube1 videos

AI synopsis

What people are saying

The overall tone of the discussions indicates a recognition of PBPK modeling as a valuable tool, with mentions of its role in regulatory support and bioequivalence assessment. Words like 'support' and references to workshops and mini-reviews highlight an engagement that is thoughtful and oriented toward practical applications, though not highly enthusiastic or critical.

AgreementModerate agreement

Most discussions acknowledge the importance and potential of PBPK modeling in the context of bioequivalence, reflecting general support.

InterestModerate interest

Participants show moderate curiosity, with some sharing resources like mini-reviews, indicating a genuine interest without overwhelming enthusiasm.

EngagementModerate engagement

The comments reference specific methods like mechanistic modeling and include mentions of workshop reports, suggesting active but measured engagement.

ImpactModerate impact

The focus on advancing regulatory tools and supporting alternative methods demonstrates recognition of the potential impact on pharmaceutical development processes.

Abstract in brief

The workshop report focuses on presentations and discussions about using physiologically based pharmacokinetic (PBPK) modeling for assessing food effects on drug bioavailability and bioequivalence, stemming from a specific session at a workshop organized by the FDA and the Center for Research on Complex Generics.
PBPK modeling is gaining traction among researchers, industry professionals, and regulatory agencies due to its effectiveness in studying how food impacts the absorption and equivalence of new and generic drugs.
The session aimed to share knowledge and address gaps in understanding PBPK modeling, with the goal of supporting further advancements in its application for generic drug development.

Read the full abstract

All mentions

Regulatory Role of PBPK Modeling in Food Impact Assessment for Bioequivalence

This workshop report highlights the use of physiologically based pharmacokinetic modeling to evaluate food effects on drug bioavailability, supporting regulatory decisions and advancements in generic drug development.

Medicine RTCL TV · Sep 6, 2023 57 views

ASCPT Journal Family

@ASCPTjournals · X

RT @RosaQSP: Bioequivalence workshop reports: PBPK modeling for assessing food impact https://t.co/BIwVb82uIQ PBPK modeling to support alte…

Jun 5, 2023 · 2 shares · 594 followers View post →

Pietro Fagiolino

@pietrofagiolino · X

RT @RosaQSP: Bioequivalence workshop reports: PBPK modeling for assessing food impact https://t.co/BIwVb82uIQ PBPK modeling to support alte…

Jun 3, 2023 · 2 shares · 36 followers View post →

Rosa for QSP

@RosaQSP · X

Jun 3, 2023 · 2 likes · 2 shares · 637 followers View post →

ASCPT Alexandria

@ASCPT_ClinPharm · X

Check out this mini-review from #PSPjournal: https://t.co/4M40qCs6mM

Jun 1, 2023 · 1,892 followers View post →